---
title: "These Analysts Think California Resources Corporation's (NYSE:CRC) Sales Are Under Threat"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285957058.md"
description: "Analysts have downgraded their revenue forecasts for California Resources Corporation (NYSE:CRC), now predicting revenues of $3.1 billion in 2026, a 12% reduction from previous estimates of $3.9 billion. This reflects a significant shift in outlook, with expected annualized revenue decline of 15% compared to historical growth of 8.1% over the past five years. In contrast, the industry is expected to grow at 3.5% per year. Overall, the downgrade raises concerns about California Resources' future performance."
datetime: "2026-05-11T14:00:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285957058.md)
  - [en](https://longbridge.com/en/news/285957058.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285957058.md)
---

# These Analysts Think California Resources Corporation's (NYSE:CRC) Sales Are Under Threat

One thing we could say about the analysts on **California Resources Corporation** (NYSE:CRC) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. This report focused on revenue estimates, and it looks as though the consensus view of the business has become substantially more conservative.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Following the latest downgrade, the current consensus, from the six analysts covering California Resources, is for revenues of US$3.1b in 2026, which would reflect a not inconsiderable 12% reduction in California Resources' sales over the past 12 months. Before the latest update, the analysts were foreseeing US$3.9b of revenue in 2026. It looks like forecasts have become a fair bit less optimistic on California Resources, given the sizeable cut to revenue estimates.

Check out our latest analysis for California Resources

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that sales are expected to reverse, with a forecast 15% annualised revenue decline to the end of 2026. That is a notable change from historical growth of 8.1% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 3.5% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - California Resources is expected to lag the wider industry.

## The Bottom Line

The most important thing to take away is that analysts cut their revenue estimates for this year. They're also anticipating slower revenue growth than the wider market. Overall, given the drastic downgrade to this year's forecasts, we'd be feeling a little more wary of California Resources going forwards.

Thirsting for more data? We have estimates for California Resources from its six analysts out until 2028, and you can see them free on our platform here.

Of course, seeing company management **invest large sums of money** in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this **free** list of stocks with high insider ownership.

### Related Stocks

- [CRC.US](https://longbridge.com/en/quote/CRC.US.md)

## Related News & Research

- [Top California Resources Executive Makes Major Insider Stock Move](https://longbridge.com/en/news/286187950.md)
- [Assessing California Resources (CRC) Valuation After Strong Multi Year Share Price Performance](https://longbridge.com/en/news/285055976.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)